“There is a very small potential benefit and significant potential harms”
Read more:
PSA testing for prostate cancer: balancing the benefits and harms
Source: BioMed Central Blog
Image credits: Lewis McChord via Creative Commons
Art and Science of Laboratory Medicine
Thursday, February 27, 2014
PSA testing for prostate cancer: balancing the benefits and harms
International consensus committees are divided in their recommendations about PSA testing. The New Zealand Ministry of Health recommends that all men over 50 should check for symptoms and undergo annual PSA testing. In the UK, however, routine PSA screening is not recommended, and men over 50 are only entitled to a PSA test if they have first discussed the benefits and harms with their doctor. The US Preventive Services Task Force (USPSTF) advises against PSA screening; co-chair Michael LeFevre highlights that:
“There is a very small potential benefit and significant potential harms”
Read more:
PSA testing for prostate cancer: balancing the benefits and harms
Source: BioMed Central Blog
Image credits: Lewis McChord via Creative Commons
“There is a very small potential benefit and significant potential harms”
Read more:
PSA testing for prostate cancer: balancing the benefits and harms
Source: BioMed Central Blog
Image credits: Lewis McChord via Creative Commons
Follow "Art and Science of Laboratory Medicine " on:
 |  |  |  |  |  |